Gpcr Dynamics: Unravelling the Complex Web of Signal Transduction
暫譯: GPCR 動力學：揭開信號傳導複雜網絡的面紗

Dr. Prashant Tiwari is a distinguished academician and researcher in pharmaceutical sciences with over 15 years of teaching and research experience across reputed institutions in India. He is currently serving as an Associate Professor at Dayananda Sagar University, Bengaluru, Karnataka. His inventive research is reflected in multiple national and international patents. These include microencapsulation of Celecoxib to improve solubility for Alzheimer's therapy, AI-driven strategies for cancer drug analysis, a smart IV fluid controller with advanced locking mechanisms. He has been awarded grants from the Department of Biotechnology, Government of India, along with seed project funding from DSU. He has authored and edited more than 30 scholarly books and chapters with leading publishers and Nirali Prakashan Notable works include The 3R's Approach in Preclinical Pharmacology (2025), Enzymatic Targets for Drug Discovery Against Alzheimer's Disease (2024) and Brain Tumor Drug Development (2024). He has organized national conferences, delivered lectures and chaired sessions internationally. His achievements have earned prestigious honors, including the SPSR Excellence Award (2025), Dr. P.D. Patil National Award (2022), Young Scientist Award (2023), IPES Fellowship (2021), and the ICMR Senior Research Fellowship (2016-2019). His pursues research in neurodegenerative diseases, drug interactions, pharmacokinetics/pharmacodynamics and metabolic disorders.

Dr. K. Sunil Kumar is an Associate Professor at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, with over 16 years of teaching and research experience. He earned his PhD in Pharmaceutical Sciences from JNTU Hyderabad and has established himself as a dedicated academician in pharmacology. His research spans neuropharmacology, metabolic disorders, organ-protective activities and drug interactions, reflecting a multidisciplinary approach. He has authored 65 research and review articles in reputed journals, five books and four book chapters, alongside six patents showcasing his innovative contributions to drug development. An active member of the Association of Pharmaceutical Teachers of India, he engages deeply with the academic community. His recent work highlights clinically relevant drug interactions, including Alprazolam with Pomegranate, Carbamazepine with Losartan and Naproxen with St. John's Wort, as well as the antiparkinsonian potential of traditional formulations like Zinda Tilismath, inspiring students and researchers alike.

Dr. Pratap Kumar Sahu is actively engaged in advanced research in neuropharmacology, with a particular focus on Alzheimer's disease and related cognitive disorders at the School of Pharmaceutical Sciences, Siksha O Anusandhan University. His recent work centers on the interplay between diabetes mellitus and neurodegeneration, exploring how metabolic dysfunction contributes to cognitive decline. He extensively investigates the repurposing of antidiabetic agents and evaluates their neuroprotective mechanisms using well‐established experimental models of AD and diabetes-induced cognitive impairment. A major component of his research involves nanotechnology-enabled drug delivery systems, including solid lipid nanoparticles, metal-based nanoformulations (AuNPs, SeNPs) and lipid nanocarriers designed to improve brain bioavailability and therapeutic efficacy of neuroprotective drugs. His publications highlight innovative approaches to enhance cognitive outcomes through nanoformulated antidiabetic compounds, paving the way for translational applications in neurodegenerative disease management. He also plays a major role in sponsored research, serving as Co-Principal Investigator in projects funded by LSRB-DRDO, ICMR and DBT BUILDER, and as Principal Investigator on an ICMR-funded project. He is a recipient of the UGC-GATE Scholarship (1999-2001), reflecting his longstanding academic excellence and deep commitment to research.

普拉尚特·提瓦里博士（Dr. Prashant Tiwari）是一位在藥學科學領域享有盛譽的學者和研究者，擁有超過15年的教學和研究經驗，曾在印度多所知名機構任教。目前，他擔任卡納塔克邦班加羅爾的達雅南達薩加大學（Dayananda Sagar University）副教授。他的創新研究體現在多項國內外專利上，包括微膠囊化Celecoxib以改善阿茲海默症治療的溶解度、基於人工智慧的癌症藥物分析策略，以及具有先進鎖定機制的智能靜脈輸液控制器。他獲得了印度政府生物技術部的資助，以及達雅南達薩加大學的種子項目資金。他已經與主要出版商和Nirali Prakashan合著和編輯了超過30本學術書籍和章節。值得注意的作品包括《臨床前藥理學中的3R方法》（2025年）、《針對阿茲海默症的藥物發現酶靶點》（2024年）和《腦腫瘤藥物開發》（2024年）。他組織了全國性會議，並在國際上發表演講和主持會議。他的成就獲得了多項榮譽，包括SPSR卓越獎（2025年）、P.D. Patil國家獎（2022年）、青年科學家獎（2023年）、IPES獎學金（2021年）和ICMR高級研究獎學金（2016-2019年）。他的研究領域包括神經退行性疾病、藥物相互作用、藥物代謝動力學/藥效學和代謝性疾病。

K. 蘇尼爾·庫馬博士（Dr. K. Sunil Kumar）是達雅南達薩加大學藥學院的副教授，擁有超過16年的教學和研究經驗。他在海得拉巴的JNTU獲得藥學博士學位，並在藥理學領域建立了自己的學術地位。他的研究涵蓋神經藥理學、代謝性疾病、器官保護活性和藥物相互作用，體現了多學科的研究方法。他在知名期刊上發表了65篇研究和綜述文章，出版了五本書籍和四個書章，並擁有六項專利，展示了他在藥物開發方面的創新貢獻。作為印度藥學教師協會的活躍成員，他與學術界深度互動。他最近的研究強調了臨床相關的藥物相互作用，包括Alprazolam與石榴、Carbamazepine與洛卡特普以及Naproxen與聖約翰草的相互作用，以及傳統配方如Zinda Tilismath的抗帕金森潛力，激勵了學生和研究者。

普拉塔普·庫馬爾·薩胡博士（Dr. Pratap Kumar Sahu）積極從事神經藥理學的前沿研究，特別專注於阿茲海默症及相關的認知障礙，任職於Siksha O Anusandhan大學的藥學院。他最近的研究集中於糖尿病與神經退行性變之間的相互作用，探討代謝功能障礙如何促進認知衰退。他廣泛研究抗糖尿病藥物的再利用，並使用已建立的阿茲海默症和糖尿病引起的認知障礙實驗模型評估其神經保護機制。他的研究主要涉及納米技術驅動的藥物傳遞系統，包括固體脂質納米顆粒、金屬基納米配方（AuNPs、SeNPs）和設計用於改善神經保護藥物腦部生物利用度和治療效果的脂質納米載體。他的出版物突顯了通過納米配方抗糖尿病化合物增強認知結果的創新方法，為神經退行性疾病管理的轉化應用鋪平了道路。他在贊助研究中也扮演重要角色，擔任由LSRB-DRDO、ICMR和DBT BUILDER資助的項目的共同首席研究員，以及一個ICMR資助項目的首席研究員。他是UGC-GATE獎學金的獲得者（1999-2001年），反映了他長期的學術卓越和對研究的深厚承諾。